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Formation of Pluripotent Stem Cells
in the Mammalian Embryo Depends
on the POU Transcription Factor Oct4
cell types, including germ cells. The ICM and its succes-
sor the epiblast are highly regulative stem cell popula-
tions that can adjust to various perturbations including
major alterations in cell number and cell position (Hogan
et al., 1994). The pool of stem cells remains pluripotent
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Brook and Gardner, 1997). Understanding the molecularGermany
basis of the pluripotent phenotype is likely to be critical
to efforts to isolate and propagate stem cells from other
species, including humans.Summary
Continued interaction with the ICM, and subsequently
the epiblast, is required to maintain proliferation of theOct4 is a mammalian POU transcription factor ex-
trophectoderm and produce a trophoblast stem cellpressed by early embryo cells and germ cells. We re-
compartment, the extraembryonic ectoderm (Gardnerport that the activity of Oct4 is essential for the identity
and Johnson, 1972; Ansell and Snow, 1975; Rossantof the pluripotential founder cell population in the
and Ofer, 1977; Papaioannou, 1982; Gardner, 1983). Re-mammalian embryo. Oct4-deficient embryos develop
ciprocal signaling from trophectoderm may similarlyto the blastocyst stage, but the inner cell mass cells
contribute to sustain the ICM/epiblast (Nichols et al.,are not pluripotent. Instead, they are restricted to dif-
1996; J. N. et al., unpublished). The diversification andferentiation along the extraembryonic trophoblast lin-
expansion of the trophoblast and ICM lineages thuseage. Furthermore, in the absence of a true inner cell
involves, first, the specification of distinct develop-
mass, trophoblast proliferation is not maintained in
mental potentials and, second, the production of para-
Oct42/2 embryos. Expansion of trophoblast precur-
crine growth signals. Elucidation of the molecular mech-
sors is restored, however, by an Oct4 target gene prod-
anisms that govern and interconnect these processes
uct, fibroblast growth factor-4. Therefore, Oct4 also
in the developing blastocyst will provide a paradigm for
determines paracrine growth factor signaling from understanding more complex tissue differentiation and
stem cells to the trophectoderm. growth control in later development.
The POU factor Oct4 (SchoÈ ler et al., 1990a; SchoÈ ler,
Introduction 1991) (also known as Oct3; Okamoto et al., 1990; Rosner
et al., 1990) is distinguished by exclusive expression
Embryonic development in mammals begins with a se- in blastomeres, pluripotent early embryo cells, and the
ries of cleavage divisions to generate a population of germ cell lineage (Rosner et al., 1990; SchoÈ ler et al.,
equivalent blastomeres. Maternal gene products depos- 1990b; Yeom et al., 1996; Pesce et al., 1998). In the
ited in the oocyte dictate a characteristic number and mouse blastocyst, Oct4 mRNA and protein are present
timing of cleavages for each species. During the cleav- in the ICM but not in the trophectoderm (Palmieri et
age process, the zygotic genome is activated and pro- al., 1994). In vitro Oct4 is found only in undifferentiated
gressively takes control of subsequent development. Cel- embryonal carcinoma (EC), embryonic stem (ES), and
lular differentiation and segregation of developmental embryonic germ (EG) cells (Okamoto et al., 1990; Rosner
lineage commence at the end of cleavage with compac- et al., 1990; Yeom et al., 1996). Oct4 can act either to
tion leading to formation of the blastocyst (Gardner and repress or to activate target gene transcription (Lenardo
Papaioannou, 1975; Papaioannou, 1982). The outer layer et al., 1989; SchoÈ ler et al., 1991; Liu and Roberts, 1996;
of cells form an epithelium, the trophectoderm, descen- Ben-Shushan et al., 1998; Botquin et al., 1998). It regu-
dants of which are restricted to generation of the tropho- lates expression of multiple genes (Saijoh et al., 1996) via
blast components of the placenta. The interior, inner cell interactions with at least two other transcription factors
mass (ICM), cells develop into pluripotent progenitors of present in pluripotent cells, the so-called E1A-like activ-
nontrophoblast extraembryonic tissues and of all fetal ity (SchoÈ ler et al., 1991) and the HMG-box protein Sox2
(Yuan et al., 1996). One of the most interesting candidate
targets of Oct4 is the gene encoding fibroblast growth
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smith@ed.ac.uk). taining enhancer in its 39 noncoding region and has been§ Present address: Institut fuÈ r Zellbiologie (Tumorforschung), Univer-
demonstrated to respond to Oct4 in a Sox2-dependentsitaÈ tsklinikum Essen, Virchowstrabe 173, D-45122 Essen, Germany.
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in the ICM and epiblast (Ma et al., 1992; Niswander and classes of embryo: nonstained, faintly stained, and mod-
Martin, 1992). erately stained (Figure 1A). PCR genotyping of several
In this paper, we demonstrate through the use of tar- embryos after staining confirmed that this profile corre-
geted gene deletion that Oct4 has a pivotal function in sponded to wild-type, heterozygous, and homozygous
the birth of the pluripotential ICM lineage. In addition, we mutant genotypes, respectively. Immunohistochemical
show that Oct4-directed expression of FGF4 provides a staining established the absence of Oct4 protein in ap-
paracrine signal that couples expansion of the extraem- proaching one-quarter (7/32) of blastocysts from in-
bryonic trophoblast lineage with development of the tercross matings (Figure 1B). Freshly isolated 3.5-day
embryonic primordium. mutant embryos resembled early blastocyst structures
in morphology. The presence of dividing cells in mutant
embryos was detected by confocal microscopy. This
Results did not reveal overt signs of cellular degeneration or
increased cell death (Figure 1C). Although partial cavita-
Embryonic Lethality of Oct4 Mutants tion was often evident, the mutant embryos were rarely
A mutant allele of Oct4 was generated via homologous fully expanded in contrast to the majority of wild-type
recombination in ES cells. Exons 2±5 of the Oct4 gene or heterozygous embryos. However, six out of six mutant
were replaced by an internal ribosome entry site (IRES)- embryos cultured in vitro from the morula stage ex-
bgeo cassette as described previously (Mountford et panded fully within 48 hr, and four hatched from the
al., 1994). The effect of this is to delete sequences en- zona. The formation of an intact trophectoderm epithe-
coding the two DNA-binding domains and the carboxy lium and the capacity to induce uterine decidualization
terminal transactivation region of the protein. In addi- indicate that any impairment of initial trophectodermal
tion, a selectable marker/reporter gene is introduced differentiation or function in the absence of Oct4 is rela-
into the locus. Germline transmission of the targeted tively minor.
allele was obtained from two independent ES clones.
The phenotype described below was found in animals
generated from both clones and was fully penetrant on Oct4-Negative Embryos Are Not Growth-Retarded
pure strain 129, hybrid-inbred (1293CBA), and hybrid- POU factors have been reported to promote cell prolifer-
outbred (1293MF1) genetic backgrounds. ation both indirectly and directly (reviewed in Ryan and
Male and female animals heterozygous for the Oct4 Rosenfeld, 1997). The possibility that Oct4 null embryos
deletion were fertile and transmitted the mutant allele were merely growth retarded was examined. Cell num-
to approximately 50% of their progeny. However, there bers in 3.5-day embryos were counted after differential
was a total absence of homozygous Oct4-deficient pups labeling of outside and inside cells (Handyside and
in 11 litters (89 pups) produced by heterozygous in- Hunter, 1984). The data presented in Figure 1D demon-
tercross matings. Furthermore, homozygous embryos strate that 3.5-day mutant embryos have normal num-
could not be found amongst 34 embryos genotyped at bers of cells in both populations. In light of this, we
midgestation. Significantly, however, high numbers of examined the possibility that cleavage development
resorption sites were detected at these and earlier might be sustained by maternal Oct4, which is abundant
stages. Six females were sacrificed at 5.5 days after
in oocytes (Rosner et al., 1990). Nuclear localized Oct4
intercross mating for examination of conceptuses prior
was detected from the 8-cell stage onward in all (37/37)
to gastrulation. Sixty-one implantation sites were ana-
embryos from wild-type matings. In contrast, 5 of 27lyzed. A total of 43 prestreak embryos were recovered.
intercross 8-cell embryos and 3 of 12 intercross morulaeThe embryos were dissected free of maternal tissue and
lacked detectable Oct4 protein (Figure 1E). Therefore,genotyped by PCR; 11 were wild type, 32 heterozygous,
maternal Oct4 does not persist through cleavage inand none homozygous for the mutant Oct4 allele. The
Oct42/2 embryos, consistent with our previous obser-remaining 18 implantation sites did not contain any dis-
vation of decay by the late 2-cell stage in wild-typecernible yolk sac or embryonic structure. They consisted
embryos (Palmieri et al., 1994). Thus, both the initialof apparently normal decidual swellings with some tro-
distribution to outside (presumptive trophectoderm) andphoblast cells evident. No material could be recovered
inside (presumptive ICM) compartments, and subsequentfree of maternal tissue for reliable genotyping, but it is
proliferation and cell survival to the mid±blastocysthighly likely that this high proportion of empty decidua
stage proceed in the complete absence of Oct4.arise from implantations of Oct4 null embryos. In a paral-
The preimplantation period was extended to deter-lel analysis of heterozygote matings to wild-type sib-
mine whether the mutant embryos had any capacitylings, only one empty site was found amongst 54 im-
for further development in vivo. Plugged females wereplantations analyzed. The wild-type and heterozygous
ovariectomized 2.5 days after copulation to prevent im-embryos from these intercrosses were at the stage of
plantation. Under these conditions, embryos mature toproamniotic cavity development and epithelialization of
the expanded blastocyst stage and then enter develop-the epiblast (Hogan et al., 1994). Thus, the absence
mental arrest (Robertson, 1987). After 5 days of implan-of Oct4 results in peri-implantation lethality before egg
tation delay, 24/24 wild-type and heterozygous blas-cylinder formation.
tocysts were fully expanded with well-defined ICMs.PCR-based genotype determination confirmed that
Homozygous Oct4-deficient mutants survived this pe-homozygous mutant preimplantation embryos were pres-
riod, but in 6/6 cases, the embryos were collapsed struc-ent at close to expected Mendelian frequency at 3.5
tures with no evident ICM.days (156/627; 24.8%), although apparently slightly un-
In order to determine the fate of mutant blastocysts,derrepresented at 4.5 days (12/75; 16%). Histochemi-
cal staining for b-galactosidase activity revealed three newly implanted embryos from intercross matings were
Oct4 and Embryonic Pluripotency
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Figure 1. Morphology, Staining, and Cell Numbers of Embryos from Intercross Matings of Oct4 Mutants
(A) b-galactosidase staining of 3.5-day blastocysts. Two embryos show light staining characteristic of heterozygotes and two show the darker
staining associated with homozygous mutants. Note the staining of the inner cells in the latter (arrow).
(B) Immunostaining of 3.5-day blastocysts for Oct4. The panel shows three embryos with immunoreactive ICMs and four nonstaining embryos.
Seven out of 32 intercross embryos examined at this stage failed to stain, whereas the inner cell mass was strongly immunoreactive in all of
more than 50 blastocysts examined from matings of wild-type mice.
(C) Confocal images after propidium iodide staining of two of the embryos shown in (B), Oct4-positive (left) and Oct4-deficient (right).
(D) Inside and outside cell numbers determined after differential labeling of freshly isolated 3.5-day embryos. Individual specimens were
recovered from the slides for genotype determination by PCR. Data are means 6 SEM. There are no significant differences within the groups
(t test, P . 0.75).
(E) Immunostaining of early morulae (2.5-day) for Oct4. Note the nuclear localization in the two positively staining embryos. Three out of 15
intercross morulae failed to stain, whereas 21/21 control embryos gave specific nuclear staining.
isolated from nascent decidual swellings at 5.0±5.25 exhibited prominent rind and core structures charac-
teristic of extraembryonic endoderm overlying epiblastdays. From 51 implantation sites, 37 embryos were re-
covered prior to proamniotic cavity formation. These all (Figure 2B). All mutant embryos, in contrast, produced
trophoblast cells only (Figure 2C).showed well-defined embryonic and abembryonic poles
(Figure 2A). They were determined to be either wild type
(18) or heterozygous (19). Eight implantations were In Vitro Development of Oct4-Deficient Embryos
The preceding observations suggested that there wasempty. The remaining six contained small, unstructured
fragments that lacked a discernible embryonic compart- a specific defect in the viability or developmental poten-
tial of the ICM in mutant embryos. The developmentalment. These fragments were genotyped by PCR and in
all cases were homozygous for the mutated allele. After status of mutant blastocysts was therefore examined
further by in vitro culture experiments. Blastocysts wereovernight culture, wild-type and heterozygous embryos
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Figure 2. Outgrowth Cultures of Intercross Embryos
(A±C) Peri-implantation stage (5.25 days) wild-type (1/1) and homozygous Oct4 mutant embryos (2/2) freshly dissected from nascent
implantation sites (A) after overnight culture (B and C). (D and E) Whole 3.5-day blastocyst cultures after 4 days. (F and G) Cultures of
immunosurgically isolated internal cells after 4 days. (D and F), Wild type; (E and G), homozygous Oct4 mutant.
Objective magnification: (A) 34; (B±G) 310.
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Table 1. In Vitro Development of Embryos from Intercross Matings of Oct4 Heterozygotes
(A) Cultures in Serum-Containing Medium
Genotype
Development 1/1 1/2 2/2 Not typed
Whole blastocysts ICM and/or endoderm 17 34 0 3
Trophoblast only 0 3 9 3
Internal cells ICM and/or endoderm 9 19 0 0
Trophoblast only 1 1 7 0
(B) Cultures in Serum-Containing Medium Supplemented with FGF4
Genotype
Development 1/1 1/2 2/2 Not typed
Whole blastocysts ICM and/or endoderm 15 27 0 0
Trophoblast only 0 0 13 2
Internal cells ICM and/or endoderm 78 134 2 10
Trophoblast only 0 2 9 2
Trophoblast 1 ªExEctº 1 1 53 4
Outgrowths were cultured for 4±6 days in Glasgow modification of Eagle's medium supplemented with 1024 M 2-mercaptoethanol, 20% fetal
calf serum, and 100 U/ml LIF. FGF4 was added to a final concentration of 2.1 ng/ml in the presence of heparin. ªExEctº refers to the emergence
of clusters of cells with morphology of extraembryonic ectoderm. The two ICM outgrowths apparently arising from Oct42/2 embryos most
likely represent errors in PCR genotyping or handling of samples.
placed in culture in ES cell derivation medium containing contain a recognizable ICM-derived structure nor pro-
duce parietal endoderm at any stage in the culture20% fetal calf serum and recombinant leukemia inhibi-
tory factor (LIF) (Nichols et al., 1990). All embryos out- period.
The absence of morphologically identifiable ICMsgrew a layer of trophoblast giant cells. Wild-type and
heterozygous embryos in addition maintained distinc- even in the earliest stages of adherent culture of mutant
blastocysts prompted more detailed investigation. Im-tive ICM-derived cell masses that increased in size dur-
ing the culture period. Migratory parietal endoderm cells munosurgery was employed to remove the outer troph-
ectoderm layer (Solter and Knowles, 1975) and isolatedifferentiated in most cultures (Figure 2D; Table 2). In
contrast, homozygous Oct4-deficient embryos yielded the internal population of cells from 3.5-day embryos.
Genotypes were determined by PCR analysis of theonly trophoblast giant cells (Figure 2E). They did not
Table 2. Second Round Targeting of the Oct4 Gene
(A) Introduction of Oct4ireshph construct into ES cells heterozygous for Oct4iresbgeo allele
Integration Event
Selection Colonies X-Gal 2 ve Random Retargeting 2nd allele
Hyg 12 9 3 9 0
Hyg 1 G418 4 0 4 0 0
(B) Introduction of Oct4iresbgeo construct into ES cells heterozygous for Oct4ireshph allele
Integration Event
Selection Colonies Xgal 1 ve Random Retargeting 2nd allele
G418 8 6 2 6 0
G418 1 Hyg 21 ND 21 0 0
G418 1 Hyga 96 8 8 0 0
(C) Introduction of Oct4ireshph construct into ES cells heterozygous for Oct4ireszeo allele and vice versa
Integration Event
Second vector Selection Colonies Random Retargeting 2nd allele
hph zeo 1 hyg 20 20 0 0
zeo zeo 3 0 3 0
zeo zeo 1 hyg 21 21 0 0
Oct4 targeting constructs were introduced into parental CGR8 ES cells or previously targeted heterozygous derivatives by electroporation
and grown up under selection in G418, hygromycin B (hyg), or zeocin (zeo) as indicated. Clones were analyzed as appropriate by X-Gal
staining for retention of the Oct4iresbgeo allele and by DNA hybridization with Oct4 genomic probes as described (Mountford et al., 1994).
a Only clones showing stem cell restricted X-Gal staining were analyzed by DNA hybridization.
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Figure 3. Cytokeratin Expression by Internal
Cells from Wild-Type and Oct4 Mutant Blas-
tocysts
Upper panel, Bright field and fluorescence
photographs of intact 3.5-day blastocysts
showing Troma-1 immunoreactivity in the
trophectoderm layer.
Lower panel, Bright field and fluorescence
photographs of immunosurgically isolated in-
ternal cells from intercross 4.5-day blasto-
cysts. No staining is evident in the heterozy-
gous ICM, whereas expression is apparent
throughout the Oct4-deficient population.
Genotypes of the internal cell clumps were
determined by PCR analysis after observa-
tion and photomicrography.
Objective magnification: 340.
trophectoderm lysate. The internal cell clumps were cul- these vectors gave a comparable high frequency (.50%)
of homologous recombinants as the bgeo construct. Intured to determine their viability and developmental po-
tential. Cultures from wild-type and heterozygous em- heterozygous cells, this frequency was maintained, but
recombination was always at the previously targetedbryos maintained a distinctive central clump of cells
with a rind and core structure. In almost all cases they allele (Table 2). When selection was applied for both
markers, only random integrants were isolated. This wasgenerated appreciable amounts of parietal endoderm
and often also patches of visceral endoderm (Figure 2F). true regardless of the order in which the targeting con-
structs were introduced. CGR8 ES cells are derived fromCells from homozygous mutant embryos also survived
in culture. However, an ICM-derived rind and core struc- pure inbred strain 129OlaHsd mice, and the frequency
of homologous recombination is expected to be identi-ture was not evident. Instead, the mutant cells flattened
out on the substratum within 24 hr of attachment and cal at both alleles. We conclude that a functional Oct4
allele is likely to be indispensable for maintenance ofinvariably differentiated into trophoblast giant cells (Fig-
ure 2G). They produced neither ICM-like growths nor the self-renewing undifferentiated ES cell phenotype.
extraembryonic endoderm (Table 1A).
These findings establish that Oct4-deficient cells in
the interior of the developing blastocyst remain viable Oct4-Negative Internal Cells Are Diverted
to a Trophoblast Fatebut do not progress to become mature ICM cells. Oct4
thus appears to be essential for the establishment of Differentiation into trophoblast of cultured inner cells
from Oct4-negative embryos could reflect prior commit-pluripotency in the ICM.
ment to the extraembryonic lineage. Alternatively, the
mutant cells may remain developmentally naive in situInactivation of Oct4 in Stem Cell Lines
In order to assess whether there is a continuous require- and initiate differentiation only in response to external-
ization, attachment to a substratum, or some other in-ment for Oct4 in the maintenance of pluripotent cells,
we attempted to inactivate both alleles in stem cell lines. ductive cue from the culture environment. To attempt
to distinguish between these two possibilities, the phe-Homozygous Oct4-negative clones could not be iso-
lated by subjecting heterozygous targeted CGR8 ES notype of mutant cells was investigated immediately
after immunosurgical isolation. The monoclonal anti-cells or P19 EC cells to selection in high levels of G418
(Mortensen et al., 1992). Further targeting vectors were body Troma-1 reacts with intermediate filaments, which
are first expressed in nascent trophectoderm and aretherefore prepared in which the IRESbgeo cassette
(Mountford et al., 1994) was substituted by either an not found in ICM cells (BruÃ let et al., 1980). Inner cell
clumps were immunostained using FITC-conjugatedIREShph or an IRESzeo marker. In parental ES cells,
Oct4 and Embryonic Pluripotency
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1997). The low levels of FGF4 transcripts detected in
some of the mutants may arise from variation in embryo
age and reflect the persistence of maternal Fgf4 mRNA
(Rappolee et al., 1994) in less advanced embryos. Alter-
natively, there may be a degree of Oct4-independent
transcription of Fgf4 in the early embryo as occurs in
later development (Niswander and Martin, 1992).
FGF4 Does Not Restore ICM Pluripotency
but Promotes Proliferation of
Trophectoderm Precursors
Recombinant FGF4 was added to cultures of Oct4 mu-
tant embryos. No effect was discernible on intact blasto-
cysts (Table 1B). Under these conditions, however, ac-
cess of growth factor to the target cells inside the
embryo may be restricted by the overlying trophecto-
Figure 4. Reverse Transcription PCR Analysis of Fgf4 Transcripts derm. FGF4 was therefore also added to cultures of
at the Blastocyst Stage immunosurgically isolated internal cells. In this case, a
Aliquots of cDNA prepared from individual 3.5-day blastocysts were marked effect was apparent in the majority of mutant
first analyzed for amplification of Oct4 sequence. Further aliquots
cultures (Table 1B). Clusters of rounded, morphologi-were then assayed for amplification of Fgf4 sequence, using incor-
cally unspecialized cells emerged from the monolayerporation of [32P]-dCTP to maximize sensitivity. Amplification of
b-actin sequence was employed as a control in both reactions. In of trophectoderm cells after 3±4 days of culture (Figure
the representative panel shown, three of the Oct4-negative samples 5). They did not originate from an ICM-like clump of
produce no detectable FGF4 amplification product and two yield a cells but grew directly out from the trophectoderm layer.
band that is ,25% the intensity of that produced from the Oct4-
These cells remained viable for at least 2 weeks, al-positive samples.
though proliferation slowed after the first few days. The
clusters were distinct in appearance from ICM-derived
structures and significantly did not give rise to either
parietal or visceral endoderm cells (compare with Figure
secondary antibody, examined by fluorescence micros-
2F). This effect was reproducibly observed on additioncopy, and then genotyped by PCR. As expected, whole
of FGF4 to inner cells isolated from either 3.5-day orblastocysts at either 3.5 days or 4.5 days gave a strong
4.5-day mutant blastocysts. The response could alsosignal localized to the trophectoderm (Figure 3 and data
be induced by FGF2 (not shown). It was specific tonot shown), but ICMs from wild-type or heterozygous
members of the FGF family, however, since it was notembryos showed no reaction (Figure 3). In contrast, Oct4
induced by serum alone, nor by two growth factors impli-null inner cells were immunoreactive with Troma-1 in
cated in trophoblast development, epidermal growthhalf of 3.5-day embryos (9 out of 18) and in all 4.5-
factor and colony stimulating factor-1.day embryos (5 out of 5) examined (Figure 3). These
In situ hybridization analysis of marker gene expres-observations indicate that the mutant cells do not remain
sion was employed to investigate the identity of theindeterminate in vivo but divert into the trophoblast lin-
FGF4-induced cells in mutant cultures. Sox2 and H19eage and begin to differentiate whilst in an internal lo-
transcripts show reciprocal expression patterns in thecation.
early embryo. Sox2 is expressed in a similar pattern
to Oct4 in the ICM and epiblast (Robin Lovell-Badge,Reduced Expression of Fibroblast Growth
personal communication) whilst H19 is expressed in tro-Factor-4 in Oct4 Mutant Embryos
phoblast and extraembryonic ectoderm (Poirier et al.,Mouse embryos lacking FGF4 form blastocysts but do
1991). Neither gene is expressed in mature parietal en-not develop significantly beyond implantation (Feldman
doderm. This specificity of expression is maintained inet al., 1995). The possible contribution of a loss of FGF4
culture (Figure 6 and data not shown). No expressionexpression to the Oct4 mutant phenotype was therefore
of Sox2 was detected in the FGF4-induced cell growthsinvestigated. RT-PCR analysis was used to determine
in mutant cultures (Figure 6B). These cells did, however,the presence or absence of Oct4, Fgf4, and b-actin tran-
express H19 at high level (Figure 6C). This confirms thatscripts in 3.5-day embryos from intercross matings. All
they are not ICM cells and strongly suggests that theyembryos contained b-actin mRNA, but Oct4 mRNA was
are trophoblastic. In appearance, these growths resem-absent in 15 out of 60 (25%). Fgf4 mRNA was present
ble primary cultures of isolated extraembryonic ecto-in all the Oct4-positive samples. Of the 15 Oct4-negative
derm that also show high expression of H19 (not shown).embryos, 6 yielded no detectable FGF4 amplification
Expression of Mash2 mRNA, a specific marker of diploidproduct, and 9 had a greatly reduced level of Fgf4 mRNA
trophoblast cells (Guillemot et al., 1994), was then inves-that was detectable only by incorporating radiolabeled
tigated. No hybridization was observed in wild-type ICMnucleotides in the PCR reaction (Figure 4). These results
cultures. However, many of the rounded cells inducedare consistent with in vitro evidence that expression of
by FGF4 treatment of Oct4 mutant cultures gave a strongFGF4 is, at least in part, dependent on Oct4 (Curatola
and Basilico, 1990; Yuan et al., 1996; Ambrosetti et al., signal (Figure 6D).
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Figure 5. Response of Internal Cells from
Oct4 Mutant Blastocysts to FGF4
Immunosurgically isolated internal cells were
cultured for 5 days in the presence of FGF4
(2.1 ng/ml) plus heparin and individual cul-
tures photographed at daily intervals. Geno-
types were determined by PCR analysis of
trophectoderm lysates.
Objective magnification: 48 and 72 hr, 315;
96 and 120 hr, 310.
These data demonstrate that FGF4 cannot rescue ICM FGF4 Is a Growth/Survival Factor for Normal
Diploid Trophectodermpluripotency in Oct4 mutants. Unexpectedly, however,
the results indicate that FGF4 promotes the expansion The preceding observations suggested that FGF4 might
be a candidate for the hitherto unidentified paracrineof diploid trophoblast precursors from mutant embryos.
Oct4 and Embryonic Pluripotency
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Figure 6. Expression of H19, Sox2, and Mash2 RNAs in Outgrowths of Wild-Type and Oct4-Deficient Embryos Cultured in the Presence of
FGF4
Immunosurgically isolated internal cells from wild-type (A) or homozygous Oct-4 mutant (B±D) 3.5-day blastocysts were cultured for 4 days
in the presence of FGF4 plus heparin, then fixed and hybridized with antisense Sox2 (A and B), H19 (C), or Mash2 (D) probes. Wild-type or
heterozygous ICMs were positive for Sox2 (4 out of 4), either negative (2 out of 5) or with patchy surface expression (3 out of 5) for H19, and
negative for Mash2 (2 out of 2). Clusters of rounded cells derived from mutant embryos were Sox2 negative (7 out of 7), uniformly positive
for H19 (10 out of 10), and positive for Mash2 (5 out of 6).
Objective magnification: 310.
growth signal from the ICM/epiblast that is required to fetal cell types. Although the morphogenetic processes
and changes in cell physiology associated with ICMmaintain proliferative diploid trophectoderm (Gardner,
1983). In order to investigate this further, the effect of development are well characterized (Hogan et al., 1994),
initiating molecular events remain obscure. In particular,FGF4 on wild-type trophectoderm cells was investi-
gated. Extraembryonic ectoderms were microsurgically no gene has previously been shown to play a specific
causal role in the formation of the pluripotent stem cellisolated from 5.5-day embryos and placed in culture in
defined medium or in serum-containing medium in either lineage. The findings reported here demonstrate such
a critical requirement for the POU factor Oct4.the presence or absence of FGF4. In both conditions,
a pronounced effect of FGF4 was evident (Figure 7). In Oct4 is abundant in the oocyte (Rosner et al., 1990),
but we have previously shown that maternal protein isthe absence of serum and FGF4, extraembryonic ecto-
derms are viable but differentiate almost entirely into degraded before the end of the 2-cell stage (Palmieri et
al., 1994). Consistent with this decay of maternal prod-trophoblast giant cells within 3±4 days. Addition of FGF4
suppresses trophoblast differentiation and maintains or uct, Oct4 protein was absent in 8 out of 42 cleavage
and early morula stage intercross embryos examined.even expands the population of undifferentiated cells. In
the presence of serum the findings are similar, although Nonetheless, Oct4-deficient embryos progress through
cleavage and compaction to form blastocyst-like struc-small clusters of undifferentiated cells do persist in the
absence of FGF4 and some giant cell differentiation tures. Normal numbers of cells are distributed to the
prospective ICM. These internal cells are viable, butoccurs in its presence. These findings show that FGF4
can support the maintenance of normal trophoblast pre- they are unable to produce extraembryonic endoderm
or other differentiated derivatives of the mature ICM incursors.
vivo or in vitro. Interestingly, however, they appear to
retain activity of the Oct4 promoter. b-galactosidaseDiscussion
activity is evident in internal cells of homozygous mutant
embryos at 3.5 days when it is already down-regulatedThe ICM is established at the first differentiation event
in mammalian embryogenesis and is the precursor of all in trophectoderm (Figure 1A). This suggests that they
Cell
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Figure 7. Maintenance of Extraembryonic
Ectoderm by FGF4
Extraembryonic ectoderms were dissected
from 5.5-day CBA3C57BL/6 F2 embryos and
cultured for 5 days in the absence or pres-
ence of FGF4 plus heparin.
(A) Cultures maintained in the absence of se-
rum in DMEM/F12 with N2 supplement
(GIBCO) were scored for differentiation into
giant cells (2) or the presence of a small (1)
or large (111) colony of morphologically un-
differentiated extraembryonic ectoderm.
(B and C) Cultures maintained in serum-con-
taining medium were fixed and stained with
Leishman's reagent to discriminate faintly
staining trophoblast giant cells and dark
staining, undifferentiated, extraembryonic
ectoderm cells. (B) Representative culture in
the presence of FGF4 showing large area of
undifferentiated cells and reduced number of
giant cells. (C) A typical culture in the absence
of FGF4 showing a large area of giant cell
differentiation with a small clump of undiffer-
entiated cells. The area of undifferentiated
cells was determined from camera lucida
drawings. This confirmed a statistically signif-
icant increase in the presence of FGF4 (Stu-
dent t test, P , 0.001; sample size, 12 em-
bryos in each group).
Objective magnification: 310.
are receptive to cues that they are inside rather than present at 4.5 days, as shown by immunosurgical isola-
tion. However, the inner clumps from mutant embryosoutside cells. Internal location should result in ICM de-
velopment (Tarkowski and Wroblewska, 1967; Gardner, were noticeably smaller than most of those from wild-
type or heterozygous sister embryos at this stage. This1983), but in the absence of Oct4 the cells cannot pro-
ceed along this path. Consequently, it is possible that suggests that mutant cells exhibit reduced or even ar-
rested proliferation, which would be consistent with theirOct4-deficient inner cells may transiently be in an inde-
terminate state. The observation that Troma-1 positivity altered identity.
The failure of FGF4 to restore pluripotency to Oct4-is only expressed by 50% of mutant embryos at 3.5 days
may be reflective of such a transient status of the inner deficient embryos is noteworthy because the Fgf4 gene
is regarded as a key Oct4 target and Fgf4 mutant em-cells. Even if this is the case, however, it is relatively
rapidly superceded by commitment to trophectoderm bryos die at the peri-implantation stage. This phenotype
has been ascribed to a failure in ICM development, al-differentiation, as revealed by cytokeratin expression in
vivo and overt trophoblast differentiation in culture. though extraembryonic endoderm clearly forms (Feld-
man et al., 1995). Recently, in fact, the notion of anThus, in the absence of Oct4, developmental potential
is restricted to the trophectoderm lineage. To our knowl- autocrine function for FGF4 in the ICM/epiblast lineage
has been thrown into question by the finding that itsedge, this phenotype has not been described amongst
the many mutants that disrupt early mouse develop- expression is not required for ES cell propagation (Wil-
der et al., 1997). Our data do not preclude a role forment. Although mutations have been described that per-
turb the subsequent growth, morphogenesis, or differ- FGF4 in ICM expansion but do demonstrate that FGF4
is not sufficient to confer pluripotential identity in theentiation of the epiblast (Haegel et al., 1995; Stephens
et al., 1995; Hakem et al., 1996; Sirard et al., 1998; Wal- absence of Oct4.
FGF receptors are expressed in trophectoderm anddrip et al., 1998), a specific failure to establish the ICM
has not been reported before. extraembryonic ectoderm (Holdener et al., 1994; Rap-
polee et al., 1994; Arman et al., 1998), consistent withThe inner cell population in mutant embryos is still
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Southern hybridization with probes external to the recombinationthe suggestion that FGF4 has a key function in trophec-
construct (Mountford et al., 1994).toderm development. Proximity to the ICM/epiblast is
All embryos were generated by natural matings. Differential cellknown to be required for maintenance of diploid troph-
counts were determined following immunolysis of the trophec-
ectoderm cells in the mouse embryo (Gardner and John- toderm and combined propidium iodide and Hoechst staining
son, 1972; Ansell and Snow, 1975), but the molecular (Handyside and Hunter, 1984). Immunosurgery was carried out as
described (Solter and Knowles, 1975) with collection of trophecto-basis of this effect has remained elusive (Gardner, 1983).
derm lysates for genotype determination by PCR. ExtraembryonicWe suggest that Oct4-directed secretion of FGF4 by
ectoderms were isolated from 5.5-day embryos separated from pri-the ICM/epiblast may constitute the signal that sustains
mary trophoblast and Reichert's membrane. Each embryo was bi-diploid trophoblast. This same mechanism may also be
sected along the embryonic/extraembryonic junction with silicon-
used to amplify extraembryonic endoderm cells follow- ized glass needles, the ectoplacental cone was removed, and the
ing the second lineage segregation event in preimplan- visceral endoderm was stripped off by drawing through a fine bore
pipette.tation development (Rappolee et al., 1994; Arman et
Embryo explant cultures were carried out in ES cell derivational., 1998). Significantly, Wilder et al. (1997) did present
medium (Glasgow modification of Eagle's medium supplementedevidence that FGF4 functions as a paracrine regulator
with 1024 M 2-mercaptoethanol, 20% fetal calf serum, and 100 U/mlof differentiated cell growth in ES cell cultures.
LIF) (Nichols et al., 1994), except for serum-free culture of extraem-
In the developing embryo, down-regulation of Oct4 bryonic ectoderm, which was performed in DMEM/F12 (50:50) with
expression correlates precisely with loss of potential to N2 supplement (GIBCO). Recombinant human FGF4, mouse FGF2,
mouse EGF, and mouse CSF-1 (M-CSF) were purchased fromform germ cells. This has led to the notion that Oct4
Sigma. FGFs were used in the presence of heparin at 1 mg/ml.may be an essential determinant of the germ line (Pesce
b-galactosidase expression was visualized by staining withet al., 1998). A premature loss of Oct4 expression in
5-bromo-4-chloro-3-indolyl b-D-galactopyranoside (X-Gal) (Bed-Smad2-deficient embryos is associated with precocious
dington and Robertson, 1989). Oct4 immunostaining was carried
differentiation of the epiblast (Waldrip et al., 1998), fur- out as described (Palmieri et al., 1994). Fluorescence confocal mi-
ther suggesting that Oct4 is an exclusive marker of pluri- croscopy was performed on propidium iodide±stained specimens
and images constructed using EMBL in-house software. Wholepotency. The evidence presented here that expression
mount in situ hybridization was carried out on paraformaldehyde-of Oct4 is crucial to the establishment of pluripotential
fixed embryo outgrowths using digoxigenin-labeled antisense RNAidentity in nascent ICM cells and probably also for main-
probes (Rosen and Beddington, 1993).taining such identity in ES cells is consistent with this
hypothesis. PCR Genotyping
This demonstration of a functional association with PCR-mediated amplification of the wild-type and mutant Oct 4 al-
pluripotency confers on Oct4 a preeminent position in leles was performed using the oligonucleotide pairs 59-TTGGGCTCC
CTTCTTGCT-39/59-AATGGGAACAGGGAAACAT-39, product 844 bp,the hierarchy of transcriptional regulators of mammalian
and 59-TGACCGCTTCCTCGTGCTTTACG-39/ 59-GCCTTCCTCTATAcell fate. POU factors are complex multifunctional pro-
GGTTGGGCTCC-39, product 545 bp, respectively. Samples wereteins that mediate pleiotropic control of gene expres-
lysed in 10±20 ml 50 mM KCl, 2.5 mM MgCl2, 0.1 mg/ml gelatin,sion. Typically, they participate in multiple protein±protein 0.45% NP40, 0.45% Tween20, 10 mM Tris.Cl (pH 8.3), with 200 mg/
interactions and can either activate or repress transcrip- ml proteinase K, and incubated at 558C for 1 hr. Following proteinase
tion, depending on context (SchoÈ ler, 1991; Annweiler et K inactivation (958C, 10 min), amplification was carried out on 1±7
ml of DNA for 30 cycles of 948C, 45 sec; 558C, 12 sec; 728C, 60 sec,al., 1992; Cleary and Herr, 1995; Ryan and Rosenfeld,
with a final extension at 728C for 10 min. Reaction products were1997; Ben-Shushan et al., 1998; Botquin et al., 1998).
resolved by agarose gel electrophoresis, transferred to nylon mem-The pluripotent germ line±competent phenotype is likely
brane, and hybridized to random hexamer-labeled probes derived
to be defined by multiple Oct4 target genes (Saijoh et from Oct4 and b-geo coding sequences.
al., 1996). Evidence that Oct4 can directly repress ex-
pression of human chorionic gonadotrophin (hCG) ex- Indirect Immunofluorescence
Groups of immunosurgically isolated internal cells from 3.5-day andpression (Liu and Roberts, 1996) is intriguing, as it sug-
4.5-day blastocysts were fixed in precooled methanol, washed ingests that a key aspect of Oct4 function may be to
PBS, and incubated in Troma-1 supernatant (1/5 dilution). After rins-suppress expression of differentiation genes. In addi-
ing through PBS, FITC-conjugated goat anti-rat Ig (Sigma) was ap-
tion, the example of FGF4 indicates that the activity of plied and staining observed and photographed using a fluorescence
some Oct4 targets may not be directed at the pluripotent microscope. Specimens were then processed individually for geno-
cells themselves. Much interest will now focus on identi- type determination by PCR.
fication of the key genes downstream of Oct4 and also
Reverse Transcription PCRon defining the mechanisms that regulate the activity
RNA isolated from individual 3.5-day embryos using RNAzol wasand expression of Oct4 itself.
converted into cDNA using oligo-dT and MMLV reverse tran-
scriptase and stored at 2208C in a final volume of 20 ml. PCRs were
carried out on 5 ml aliquots in a total reaction volume of 25 ml. Pri-Experimental Procedures
mer sets were as follows: b-actin 59-GGCCCAGAGCAAGAGAGGTA
TCC-39/ 59-ACGCACGATTTCCCTCTCAGC-39, product 460 bp; Oct4ES Cell Culture and Embryo Manipulation
CGR8 ES cells (Mountford et al., 1994) and derivatives were cultured 59-GGCGTTCTCTTTGGAAAGGTGTTC-39/59-CTCGAACCACATCC
TTCTCT-39, product 312 bp; Fgf4 59-AGCGAGGCGTGGTGAGCAwithout feeders in LIF-supplemented medium (Smith, 1991). Chime-
ras were produced by microinjection into C57BL/6 blastocysts TCTT-39/59-TGGTCCGCCCGTTCTTACTGAG-39, product 175 bp.
Amplification was achieved by 45 cycles of 948C, 30 sec; annealing(Schwartzberg et al., 1989) and crossed with outbred MF1 females.
Germline chimeras were subsequently mated directly with CBA/ T, 60 sec; 728C, 60 sec, followed by a final incubation for 5 min at
728C. Two primer sets were used in each reaction and each embryoCa or 129/OlaHsd mice to generate hybrid inbred lines. Mice were
backcrossed at least once before analysis of heterozygous inter- cDNA was analyzed with all three combinations: b-actin/Oct4 (an-
nealing at 628C), b-actin/Fgf4 (annealing at 648C), and Fgf4/Oct4crosses. Transmission of the deleted Oct4 allele was monitored by
Cell
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(annealing at 638C). Products were resolved by agarose gel electro- Feldman, B., Poueymirou, W., Papaioannou, V.E., DeChiara, T.M.,
and Goldfarb, M. (1995). Requirement of FGF-4 for postimplantationphoresis and visualized by ethidium bromide staining. For quantita-
mouse development. Science 267, 246±249.tion, PCR was carried out in the presence [32P]-dCTP and gel-sepa-
rated products quantified by phosphoimage analysis. Gardner, R.L. (1983). Origin and differentiation of extra-embryonic
tissues in the mouse. Int. Rev. Exp. Pathol. 24, 63±133.
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